文献速递性腺与生殖内分泌

基于人群与健康系统及保险理赔记录:多囊卵巢综合征存在显著诊断不足

Population-Based vs Health System and Insurer Records: Significant Underdiagnosis of PCOS.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该系统检索 PubMed 和 Embase 截至 2023 年 7 月,纳入美国、英国、韩国同一人群中 7 项基于人群的研究和 11 项基于健康系统或保险理赔记录(HSIR)的研究。美国基于人群研究报告的多囊卵巢综合征患病率为 4%~19.6%,HSIR 研究为 0.2%~5.2%;英国 HSIR 为 1.34%,人群约 8%;韩国基于人群研究为 4.9%和 7%,而一项 HSIR 为 0.12%~0.33%,另一项为 4.3%。结论认为 HSIR 中的多囊卵巢综合征检出率远低于人群研究,提示诊断不足和/或报告不足。

要点

  • 美国人群研究多囊卵巢综合征患病率 4%~19.6%,HSIR 仅 0.2%~5.2%
  • 英国 HSIR 患病率 1.34%,人群约 8%
  • 韩国人群研究 4.9%和 7%,一项 HSIR 仅 0.12%~0.33%

核心结论

  • HSIR 中多囊卵巢综合征发生率明显低于美国、英国和韩国基于人群的研究,可能提示多囊卵巢综合征诊断不足和/或报告不足。
  • 作者认为这些发现凸显需要提高卫生保健从业者、支付方以及可能公众对多囊卵巢综合征的认识。

研究设计与样本

  • 系统检索 PubMed 和 Embase 截至 2023 年 7 月,纳入来自 3 个国家同一人群的 7 项基于人群的研究和 11 项基于 HSIR 的研究。

主要发现

  • 美国基于人群研究报告的多囊卵巢综合征患病率为 4%~19.6%,HSIR 研究报告为 0.2%~5.2%。
  • 英国一项 HSIR 研究报告多囊卵巢综合征患病率为 1.34%,而人群中约为 8%。
  • 韩国 2 项基于人群研究报告多囊卵巢综合征患病率为 4.9%和 7%,一项 HSIR 为 0.12%~0.33%,另一项 HSIR 为 4.3%。
  • 在有数据时,HSIR 中多囊卵巢综合征检出率似乎随时间改善,但仍远未反映人群中的实际患病率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is one of the most prevalent cardio-metabolic disorders in women. However, PCOS diagnosis is often missed or delayed, which may have serious physical and mental health consequences. The extent of underdiagnosis remains unknown. OBJECTIVE: This work aimed to estimate the extent to which PCOS is underdiagnosed. METHODS: We systematically searched PubMed and Embase through July 2023 for studies reporting PCOS prevalence in the general population and the Health System or Insurer Records (HSIR). RESULTS: We identified 6583 records, of which we included 7 population-based studies and 11 HSIR-based studies from the same populations in 3 countries. In the United States, population-based studies reported a PCOS prevalence between 4% and 19.6%, while HSIR-based studies reported 0.2% to 5.2%. In the United Kingdom, an HSIR-based study reported a PCOS prevalence of 1.34%, compared to around 8% prevalence in the population. In South Korea, 2 population-based studies reported a PCOS prevalence of 4.9% and 7%, compared to 0.12% to 0.33% in one HSIR, and 4.3% in another. When data were available, PCOS detection in HSIR appeared to improve over time, although it was still far from reflecting the actual prevalence in the population. CONCLUSION: Our data revealed a substantially lower rate of PCOS in HSIR relative to population-based studies in the United States, the United Kingdom, and South Korea, likely indicating that PCOS is underdiagnosed and/or underreported. Overall, these findings highlight the critical need to improve the awareness of health care practitioners and payers, and likely the public at large, regarding PCOS.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hatoum S, Amiri M, Hopkins D, et al. Population-Based vs Health System and Insurer Records: Significant Underdiagnosis of PCOS. J Clin Endocrinol Metab. 2025. PMID: 39833660. doi:10.1210/clinem/dgaf037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。